about
Animal models of substance abuse and addiction: implications for science, animal welfare, and societyAbuse liability assessment of tobacco products including potential reduced exposure productsThe safety and tolerability of zolpidem--an update.Abuse Potential of Soma: the GABA(A) Receptor as a TargetComparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsAbuse liability assessment of neuroprotectants.A review of human drug self-administration procedures.Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones.A comparative, developmental, and clinical perspective of neurobehavioral sexual dimorphismsΔ9-Tetrahydrocannabinol-like discriminative stimulus effects of compounds commonly found in K2/Spice.Dose-response analysis in risk assessment: evaluation of behavioral specificity.The role of acetylcholine in cocaine addiction.Abuse liability of the dietary supplement dimethylamylamine.New perspectives in CNS safety pharmacology.Neuropharmacology of the interoceptive stimulus properties of nicotine.The cognitive effect profiles of NMDA receptor modulating drugs are resolvable if stimulus complexity is varied in a number discernment task.Blowing smoke: how cigarette manufacturers argued that nicotine is not addictiveAnalysis of opioid efficacy, tolerance, addiction and dependence from cell culture to humanOn the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse.GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vaporΔ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market.Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicleThe reinforcement threshold for nicotine as a target for tobacco control.Nicotine and methamphetamine share discriminative stimulus effectsGABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice.The neurocircuitry of addiction: an overview.Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.Controversies in translational research: drug self-administration.Self-administration of cocaine, cannabis and heroin in the human laboratory: benefits and pitfalls.Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration.The latest evidence in the neuroscience of solvent misuse: an article written for service providers.Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.Discriminative stimulus effects of ethanol in C57BL/6J and DBA/2J inbred mice.Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference.
P2860
Q30433958-E9C219C3-E407-46A8-BD50-4A6BE7EC5752Q33559301-31411FC4-88C4-49E6-AD88-DB5BF4B41D54Q33604198-8F197583-AAC6-450B-B0D5-ADA9C1A84640Q33805864-78AE7856-5917-43DD-AD04-319B874ACE10Q33833054-D41C15B3-739A-4139-BD2D-5D6A4BF08293Q33834208-B0FC0D9C-D002-406A-9DD1-901E262B0139Q33841805-051F0C36-D9F2-49C1-B6D7-C3B594B88BA3Q34280393-56D23316-570E-4B00-8A69-F652BBC961E2Q34304922-FA6E2FA8-62FD-4011-A550-E3BF2DCBAF8EQ34437634-F20E9AEB-2D2E-481B-8B9C-2803F58AADA7Q34636663-D417B7A9-FCD2-4469-96A8-BFB4434E97B4Q34700186-501D13B7-74E6-42BB-9A84-5C0A7EE7C3DAQ34749168-CCC4A6DD-071F-4166-ACFE-7D15B7281091Q34775504-8F69085D-8033-47C8-AA18-1C6AE9BF923EQ34906263-DA3EE7C9-BDAB-492E-8DB4-4B54ECB5C115Q35294384-02533BA1-79AC-4465-954D-D9094723CECBQ35565021-37B2C1A8-EFA6-43E3-9B90-56A59DF2B156Q35589969-AB3182F2-9A06-430F-A9BE-B8472D7679B9Q35608751-3EFFD601-1D71-4DE1-A3A8-C190E088401FQ35670267-818F6B68-546F-4F48-8C54-8BC704A49D0DQ35836423-6D5B4A67-EB7D-45CE-9F51-564F9B562840Q36068409-237A8D14-9AB7-488A-8BDD-D43E4BEF5104Q36164835-4AFC4E86-2A25-4854-BED7-AFE35D734C3EQ36649143-E66B1E0A-346C-4255-B290-A3E3D973F48FQ36665024-4B3CD8E9-5B9E-4CA1-BA94-969C955EE151Q36741890-C7A20A7B-AEED-4BCC-A043-81E41C026376Q36783972-9814CE67-AE82-418C-9D46-9C32C902160EQ37087986-C1482F3C-A8A1-497E-8BC1-B63709BDFFD6Q37294513-2A38DBAC-AF31-49C0-B22E-CD74AEE9B355Q37465327-C1ED91D1-C708-43B9-B011-D04F752D4290Q37879128-997838E3-BA0F-42B6-B765-BE3953C1AC3BQ40170517-D4A85A2E-767A-40EA-931E-AF1D6B08BF6FQ44030551-F7AA270D-9DAE-4CF2-88EB-1BCA0DD26BF4Q47985118-001E914F-5D4F-45C8-A527-57E2DF65F7F1
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Drug abuse potential evaluation in animals.
@ast
Drug abuse potential evaluation in animals.
@en
Drug abuse potential evaluation in animals.
@nl
type
label
Drug abuse potential evaluation in animals.
@ast
Drug abuse potential evaluation in animals.
@en
Drug abuse potential evaluation in animals.
@nl
prefLabel
Drug abuse potential evaluation in animals.
@ast
Drug abuse potential evaluation in animals.
@en
Drug abuse potential evaluation in animals.
@nl
P2860
P1476
Drug abuse potential evaluation in animals.
@en
P2093
Balster RL
P2860
P304
P356
10.1111/J.1360-0443.1991.TB01747.X
P577
1991-12-01T00:00:00Z